S. Yerly

Discipline

Psychologie (2) Economies et finances (2) Sociologie (1)

Type de document

Articles (58)

Co-auteur

Date

Source

Mot-clé

Patients (37) Patients (37) cohorte (33) Treatment (32) Swiss (30) Human beings (30) thérapie (29) Therapeutics (29) Methods (27) Infection (27) Methods (27) virus (26) infection (26) temps (durée) (23) Immunodeficiency (23) Time (23) résistance (23) Drug resistance (22) Transmission (21) Population (18) art (17) analyse (17) Art (17) Art (17) Art (17) Analysis (17) art (17) mutation (16) adulte (16) Population (16)

Documents écrit par S. Yerly (58) | parle de S. Yerly (0)

Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, Switzerland.
S. Stringhini et al. (8 juin 2021)
Systematic screening of viral and human genetic variation identifies antiretroviral resistance and immune escape link.
H. Nguyen et al. (1 juin 2021)
SARS-CoV-2 N501Y Introductions and Transmissions in Switzerland from Beginning of October 2020 to February 2021-Implementation of Swiss-Wide Diagnostic Screening and Whole Genome Sequencing.
A.R. Goncalves Cabecinhas et al. (25 mars 2021)
Heritability of the HIV-1 reservoir size and decay under long-term suppressive ART.
C. Wan et al. (2 nov. 2020)
Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL'HIV trial.
D. Sculier et al.
HCV Genetic Diversity Can Be Used to Infer Infection Recency and Time since Infection.
L.A. Carlisle et al. (31 oct. 2020)
Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients.
F. Olearo et al.
Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART.
N. Bachmann et al. (19 juil. 2019)
Inferring the age difference in HIV transmission pairs by applying phylogenetic methods on the HIV transmission network of the Swiss HIV Cohort Study.
K. Kusejko et al.
Stable HIV-1 reservoirs on dolutegravir maintenance monotherapy: the MONODO study.
D. Sculier et al. (22 juin 2018)
Distinct, IgG1-driven antibody response landscapes demarcate individuals with broadly HIV-1 neutralizing activity.
C. Kadelka et al. (4 juin 2018)
The Cumulative Impact of Harm Reduction on the Swiss HIV Epidemic: Cohort Study, Mathematical Model, and Phylogenetic Analysis.
A. Marzel et al.
Quantifying the fitness cost of HIV-1 drug resistance mutations through phylodynamics.
D. Kühnert et al.
Dissecting HIV Virulence: Heritability of Setpoint Viral Load, CD4+ T-Cell Decline, and Per-Parasite Pathogenicity.
F. Bertels et al. (1 janv. 2018)
Assessing the danger of self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysis.
T. Turk et al. (12 sept. 2017)
A Direct Comparison of Two Densely Sampled HIV Epidemics: The UK and Switzerland.
M.L. Ragonnet-Cronin et al. (19 sept. 2016)
Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs.
C.S. Oberle et al. (5 sept. 2016)
Genotypic Resistance Tests Sequences Reveal the Role of Marginalized Populations in HIV-1 Transmission in Switzerland.
M. Shilaih et al. (14 juin 2016)
Incident Hepatitis C Virus Infections in the Swiss HIV Cohort Study : changes in treatment uptake and outcomes between 1991 and 2013
G. Wandeler et al. (2015)
Decreasing Proportion of Recent Infections among Newly Diagnosed HIV-1 Cases in Switzerland, 2008 to 2013 Based on Line-Immunoassay-Based Algorithms.
J. Schüpbach et al. (2015)
Increases in condomless sex in the Swiss HIV Cohort Study.
R.D. Kouyos et al. (2015)
Persistence of Transmitted HIV-1 Drug Resistance Mutations Associated with Fitness Costs and Viral Genetic Backgrounds.
W.L. Yang et al. (2015)
Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012.
W.L. Yang et al. (2015)
Aviremia 10 Years Postdiscontinuation of Antiretroviral Therapy Initiated During Primary Human Immunodeficiency Virus-1 Infection and Association With Gag-Specific T-Cell Responses.
S. Kinloch-de Loes et al. (2015)
Assessing efficacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the Swiss HIV Cohort Study.
W.L. Yang et al. (2015)

next